Skip to main content
You Rang The Bell Now Let's Beat The Odds

More than 1 in 3 people with early breast cancer are at risk of cancer coming back based on diagnosis and risk factors


Being told you’re “cancer free" is an important milestone in the early breast cancer journey (stages 1, 2, 3). However, the science shows that despite initial treatment success after surgery, chemotherapy, and/or radiation, there's still a chance cancer can come back. If cancer does return after treatment, it’s called a recurrence

Just remember, everybody’s journey with breast cancer is unique. We want to help you move forward with confidence, equipped with better understanding about your risk of cancer coming back and the key questions to ask your doctor.

Get access to helpful resources

* Required fields

Are you looking for information for yourself or a loved one?

By clicking SUBMIT, you represent that you are 18 years of age or older and agree to the Novartis Pharmaceuticals Corporation (NPC) Terms of Use. You understand and agree that the information you provide will be used in accordance with the NPC Privacy Policy, and to provide you with marketing information, offers, and promotions, and to contact you for your opinions regarding products, programs, and services. NPC may also show you relevant health-related advertisements when you visit other websites. To learn about our interest-based ads, click hereYou understand that unless you unsubscribe, by calling 1-888-669-6682 or clicking unsubscribe in a promotional email, your consent will remain valid.

*Oncotype DX is a registered trademark of Exact Sciences Corporation; MammaPrint is a registered trademark of Agendia, Inc; Prosigna is a
registered trademark of Veracyte, Inc; Breast Cancer Index is a registered trademark of Hologic, Inc; EndoPredict is a registered trademark of Myriad Genetics Inc.
This is not an exclusive list of organizations. All of these organizations are not-for-profit, and are independent from Novartis Pharmaceuticals Corporation. Novartis has no financial interest in any organization listed, but may provide occasional funding support to these organizations. All trademarks referenced are the property of their respective owners.